دورية أكاديمية
أعرض في EDS

How does genetic testing influence anxiety, depression, and quality of life? A hereditary breast and ovarian cancer syndrome suspects trial.

التفاصيل البيبلوغرافية
العنوان: How does genetic testing influence anxiety, depression, and quality of life? A hereditary breast and ovarian cancer syndrome suspects trial.
المؤلفون: Oliveira FFB; Department of Psychology, Hospital Haroldo Juaçaba, the Ceará Cancer Institute, Fortaleza, Brazil.; Laboratory of Genetics and Molecular Biology, Hospital Haroldo Juaçaba, the Ceará Cancer Institute, Fortaleza, Brazil., de Barros Silva PG; Laboratory of Genetics and Molecular Biology, Hospital Haroldo Juaçaba, the Ceará Cancer Institute, Fortaleza, Brazil., de Sant'Ana RO; Laboratory of Genetics and Molecular Biology, Hospital Haroldo Juaçaba, the Ceará Cancer Institute, Fortaleza, Brazil.; Department of Clinical Oncology/Oncogenetics, Hospital Haroldo Juaçaba, the Ceará Cancer Institute, Fortaleza, Brazil.; Medical School, University of Fortaleza (UNIFOR), Fortaleza, Brazil., de Albuquerque CGP; Laboratory of Genetics and Molecular Biology, Hospital Haroldo Juaçaba, the Ceará Cancer Institute, Fortaleza, Brazil., Bezerra MJB; Laboratory of Genetics and Molecular Biology, Hospital Haroldo Juaçaba, the Ceará Cancer Institute, Fortaleza, Brazil., Wong DVT; Laboratory of Genetics and Molecular Biology, Hospital Haroldo Juaçaba, the Ceará Cancer Institute, Fortaleza, Brazil., da Silveira Bitencourt F; Department of Clinical Oncology/Oncogenetics, Hospital Haroldo Juaçaba, the Ceará Cancer Institute, Fortaleza, Brazil., de Lima Silva-Fernandes IJ; Laboratory of Genetics and Molecular Biology, Hospital Haroldo Juaçaba, the Ceará Cancer Institute, Fortaleza, Brazil. isabelle.silva@icc.org.br., Lima MVA; Laboratory of Genetics and Molecular Biology, Hospital Haroldo Juaçaba, the Ceará Cancer Institute, Fortaleza, Brazil.
المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Jul; Vol. 29 (7), pp. 3521-3530. Date of Electronic Publication: 2020 Nov 05.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin : Springer International, c1993-
مواضيع طبية MeSH: Anxiety/*psychology , Depression/*psychology , Genetic Testing/*methods , Hereditary Breast and Ovarian Cancer Syndrome/*psychology , Quality of Life/*psychology, Cross-Sectional Studies ; Female ; Hereditary Breast and Ovarian Cancer Syndrome/genetics ; Humans ; Middle Aged ; Surveys and Questionnaires
مستخلص: Background: Emotional distress associated with genetic testing for hereditary breast and ovarian cancer syndrome (HBOC) is reported to interfere with adherence to treatment and prophylactic measures and compromise quality of life.
Objectives: To determine levels of anxiety, depression, and quality of life in patients tested for pathogenic BRCA1/2 mutations and identify risk factors for the development of adverse psycho-emotional effects.
Methods: Cross-sectional observational trial involving 178 breast or ovarian cancer patients from a referral cancer hospital in Northeastern Brazil. Information was collected with the Hospital Anxiety and Depression Scale (HADS) and the World Health Organization (WHO) Quality of Life (QoL) questionnaire (WHOQOL-BREF).
Results: Patients suspected of HBOC had higher levels of anxiety than depression. The presence of (probably) pathogenic BRCA1/2 mutations did not affect levels of anxiety and depression. High schooling, history of psychiatric disease, and use of psychotropic drugs were directly associated with high anxiety. High schooling was too inversely associated with QoL as such a breast tumor. Anxiety and depression were directly correlated and both reduced significantly QoL.
Conclusion: Our results highlight the importance of psychological support and screening of risk factors for anxiety and depression and low QoL in HBOC patients at the time of testing.
References: Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, BRCA and BRCA Cohort Consortium (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402–2416. https://doi.org/10.1001/jama.2017.7112. (PMID: 10.1001/jama.2017.711228632866)
Bercow AS, Eisenhauer EL (2019) Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer. J Surg Oncol 120(5):864–872. https://doi.org/10.1002/jso.25645. (PMID: 10.1002/jso.2564531355450)
Telli ML, Gradishar WJ, Ward JH (2019) NCCN guidelines updates: breast cancer. J Natl Compr Cancer Netw 17(5.5):552–555. https://doi.org/10.6004/jnccn.2019.5006. (PMID: 10.6004/jnccn.2019.5006)
Domchek SM, Christian FS, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van t’veer L, Tung N, Weitzel JN, Couch FJ, Rubinstein JS, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Schildkraut J, Blum JL, Rebbeck TR (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975. https://doi.org/10.1001/jama.2010.1237. (PMID: 10.1001/jama.2010.1237208103742948529)
Bober SL, Recklitis CJ, Bakan J, Garber JE, Patenaude AF (2015) Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention. J Sex Med 12(1):189–197. https://doi.org/10.1111/jsm.12713. (PMID: 10.1111/jsm.1271325311333)
Noguès C, Mouret-Fourme E (2012) Prophylactic surgery in common hereditary cancer syndromes. Bull Acad Natl Med 196(7):1237–1245. (PMID: 23815011)
Brédart A, Kop JL, Depauw A, Caron O, Sultan S, Leblond D, Fajac A, Buecher B, Gauthier-Villars M, Noguès C, Flahault C, Stoppa-Lyonnet D, Dolbeault S (2013) Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer. Br J Cancer 108(5):1012–1020. https://doi.org/10.1038/bjc.2012.599. (PMID: 10.1038/bjc.2012.599234627253619058)
Mella S, Muzzatti B, Dolcetti R, Annunziata MA (2017) Emotional impact on the results of BRCA1 and BRCA2 genetic test: an observational retrospective study. Hered Cancer Clin Pract 15:16. https://doi.org/10.1186/s13053-017-0077-6. (PMID: 10.1186/s13053-017-0077-6290264495625658)
Bylund CL, Fisher CL, Brashers D, Edgerson S, Glogowski EA, Boyar SR, Kemel Y, Spencer S, Kissane D (2012) Sources of uncertainty about daughters' breast cancer risk that emerge during genetic counseling consultations. J Genet Couns 21(2):292–304. https://doi.org/10.1007/s10897-011-9400-y. (PMID: 10.1007/s10897-011-9400-y21833819)
Di Mattei VE, Carnelli L, Bernardi M, Bienati R, Brombin C, Cugnata F, Rabaiotti E, Zambetti M, Sarno L, Candiani M, Gentilini O (2018) Coping mechanisms, psychological distress, and quality of life prior to cancer genetic counseling. Front Psychol 9:1218. https://doi.org/10.3389/fpsyg.2018.01218. (PMID: 10.3389/fpsyg.2018.01218300618536055025)
Di Mattei VE, Duchini E, Zucchi P, Patricelli MG, Rognone A, Di Pierro R, Zambetti M, Sarno L (2015) Consulenza genetica oncologica e qualità di vita: il ruolo delle strategie di coping e della sintomatologia psicopatologica nella fase pre-testale. Recenti Prog Med 106(8):380–384. https://doi.org/10.1701/1960.21304. (PMID: 10.1701/1960.2130426228860)
Listol W, Hoberg-Vetti H, Eide GE, Bjorvatn C (2017) Anxiety and depression symptoms among women attending group-based patient education courses for hereditary breast and ovarian cancer. Hered Cancer Clin Pract 15:2. https://doi.org/10.1186/s13053-016-0062-5). (PMID: 10.1186/s13053-016-0062-5)280969035225510)
Ringwald J, Wochnowski C, Bosse K, Giel KE, Schaffeler N, Zipfel S, Teufel M (2016) Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation carriers: a systematic review. J Genet Couns 25(5):880–891. https://doi.org/10.1007/s10897-016-9949-6. (PMID: 10.1007/s10897-016-9949-627074860)
MacDonald D, Sarna L, Weitzel JN, Ferrel B (2010) Women’s perceptions of personal and family impact of genetic risk assessment: focus group findings. J Genet Couns 19(2):148–160. https://doi.org/10.1007/s10897-009-9267-3. (PMID: 10.1007/s10897-009-9267-319902342)
Corines MJ, Hamilton JG, Glogowski E, Anrig CA, Goldberg R, Niehaus K, Salo-Mullen E, Harlan M, Sheehan MR, Trottier M, Ahsraf A, Tran C, Jacobs L, Rau-Murthy R, Lincoln AG, Robson ME, Guillem JG, Markowitz AJ, Offit K, Stadler ZK (2017) Educational and psychosocial support needs in Lynch syndrome: implementation and assessment of an educational workshop and support group. J Genet Couns 26(2):232–243. https://doi.org/10.1007/s10897-016-0015-1. (PMID: 10.1007/s10897-016-0015-127734221)
El-Husny A, Raiol-Moraes M, Amador M, Ribeiro-dos-Santos AM, Montagnini A, Barbosa S, Silva A, Assumpção P, Ishak G, Santos S, Pinto P, Cruz A, Ribeiro-dos-Santos A (2016) CDH1 mutations in gastric cancer patients from northern Brazil identified by next-generation sequencing (NGS). Genet Mol Biol 39(2):189–198. https://doi.org/10.1590/1678-4685-GMB-2014-0342. (PMID: 10.1590/1678-4685-GMB-2014-0342271921294910547)
Botega NJ, Bio MR, Zomignani MA, Garcia JRC, Pereira WAB (1995) Mood disorders among medical in-patients: a validation study of the hospital anxiety and depression scale (HAD). Rev Saúde Pública 29(5):355–363. https://doi.org/10.1590/S0034-89101995000500004. (PMID: 10.1590/S0034-891019950005000048731275)
Fleck MPA, Louzada S, Xavier M, Chachamovitch E, Vieira G, Santos L, Pinzon V (2000) Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref. Rev Saúde Pública 34(2):178–183. https://doi.org/10.1590/S0034-89102000000200012. (PMID: 10.1590/S0034-8910200000020001210881154)
Mansano-Schlosser TC, Ceolim MF (2012) Quality of life of cancer patients during the chemotherapy period. Text Context Nursing 21(3):600–607. https://doi.org/10.1590/S0104-07072012000300015.
Bennett P, Wilkinson C, Turner J, Cérebro K, Edwards RT, Griflith B, França B, Cinzento J (2008) Psychological factors associated with emotional responses to receiving genetic risk information. J Genet Couns 17(3):234–241. https://doi.org/10.1007/s10897-007-9136-x. (PMID: 10.1007/s10897-007-9136-x18259848)
Cicero L, De Luca R, Dorangricchia P, Lo Coco L, Guarnaccia C, Fanale D, Calò V, Russo A (2017) Risk perception and psychological distress in genetic counselling for hereditary breast and/or ovarian cancer. J Genet Couns 26(5):999–1007. https://doi.org/10.1007/s10897-017-0072-0. (PMID: 10.1007/s10897-017-0072-028283917)
González-Ramírez LP, Martínez-Arraiga R, Camacho-Cárdenas E, Toro-Valero AD, Oceguerra-Villanueva A, Zagamé L, Silva-García AA, Daneri-Navarro A (2017) Evaluation of psychosocial aspects in participants of cancer genetic counseling. Hered Cancer Clin Pract 15:13. https://doi.org/10.1186/s13053-017-0073-x. (PMID: 10.1186/s13053-017-0073-x289439895607594)
Beitsch PD, Whitworth PW, Hughes K, Patel R, Rosen R, Compagnoni G, Baron P, Simmons R, Smith LA, Grady I, Kinney M, Coomer C, Barbosa K, Holmes DR, Brown E, Gold L, Clark P, Riley L, Lyons S, Ruiz A, Kahn S, MacDonald H, Curcio L, Hardwick MK, Yang A, Esplin ED, Nussbaum RL (2019) Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J Clin Oncol 37(6):453–460. https://doi.org/10.1200/JCO.18.01631. (PMID: 10.1200/JCO.18.0163130526229)
Eijzenga W, Bleiker EMA, Hahn DEE, Van der Kolk LE, Sidharta GN, Aaronson NK (2015) Prevalence and detection of psychosocial problems in cancer genetic counseling. Familial Cancer 14(4):629–636. https://doi.org/10.1007/s10689-015-9809-9. (PMID: 10.1007/s10689-015-9809-9259688074630247)
Dorval M, Patenaude AF, Schneider KA, Kieffer SA, DiGianni L, Kalkbrenner KJ, Bromber JI, Basili LA, Calzone K, Stopfer J, Weber BL, Garber JE (2000) Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. J Clin Oncol 18(10):2135–2142. https://doi.org/10.1200/JCO.2000.18.10.2135. (PMID: 10.1200/JCO.2000.18.10.213510811679)
Bonadona V, Saltel P, Desseigne F, Mignotte H, Saurin JC, Wang Q, Sinilnikova O, GiraudS FG, Plauchu H, Puisieux A, Lasset C (2002) Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiol Biomark Prev 11(1):97–104.
Hirschberg AM, Chan-Smutko G, Pirl WF (2015) Psychiatric implications of cancer genetic testing. Cancer 121(3):341–360. https://doi.org/10.1002/cncr.28879. (PMID: 10.1002/cncr.2887925234846)
Almeida TG, Comassetto I, Alves KMC, Santos AAP, Silva JMO, Trezza MCSF (2015) Experience of young women with breast cancer and mastectomized. Esc Anna Nery 19(3):432–438. https://doi.org/10.5935/1414-8145.20150057.
Nicolussi AC, Sawada NO (2011) Quality of life of breast cancer patients on adjuvant therapy. Rev Gaúcha Enferm 32(4):759–766. https://doi.org/10.1590/S1983-14472011000400017. (PMID: 10.1590/S1983-1447201100040001722299279)
Lotti RCB, Barra AA, Dias RC, Makluf ASD (2008) Breast cancer treatment and its impact on quality of life. Rev Bras Cancerol 54(4):367–371.
Liede A, Metcalfe K, Hanna D, Hoodfar E, Snyder C, Durham C, Lynch HT, Narod AS (2000) Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. Am J Hum Genet 67(6):1494–1504. https://doi.org/10.1086/316907. (PMID: 10.1086/316907110636721287926)
Finch A, Metcalfe KA, Chiang JK, Elit L, McLaughlin J, Springate C, Demsky R, Murphy J, Rosen B, Narod SA (2011) The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol 121(1):163–168. https://doi.org/10.1016/j.ygyno.2010.12.326. (PMID: 10.1016/j.ygyno.2010.12.32621216453)
Tannock IF, Wit R, Berry WR, Horti J, Pluzanska A, Oudard S, Théodore C, James ND, Turesson I, Rosenthal MA, Eisenberg MA (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351(1):1502–1512. https://doi.org/10.1056/NEJMoa040720. (PMID: 10.1056/NEJMoa040720)
Eisenbraun J, Scheer R, Kröz M, Schad F, Huber R (2011) Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract. Phytomedicine 18(2-3):151–157. https://doi.org/10.1016/j.phymed.2010.06.013. (PMID: 10.1016/j.phymed.2010.06.01320724129)
Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, Gralow J (2008) Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry 30(2):112–126. https://doi.org/10.1016/j.genhosppsych.2007.10.008. (PMID: 10.1016/j.genhosppsych.2007.10.00818291293)
Chintamani, Gogne A, Khandelwal R, Tandon M, Jain S, Kumar Y, Narayan N, Bamal R, Srinivas S, Saxena S (2011) The correlation of anxiety and depression levels with response to neoadjuvant chemotherapy in patients with breast cancer. JRSM Short Rep 2(3):15. https://doi.org/10.1258/shorts.2010.010072. (PMID: 10.1258/shorts.2010.010072215410833086323)
Kim S, Akpati HC, Li JG, Liu CR, Amdur RJ, Palta JR (2004) An immobilization system for claustrophobic patients in head-and-neck intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 59(5):1531–1539. https://doi.org/10.1016/j.ijrobp.2004.01.025. (PMID: 10.1016/j.ijrobp.2004.01.02515275741)
Snyder C (2016) Evolution of cancer risk assessment and counseling related to psychological, financial and legal implications. Familial Cancer 15(3):493–496. https://doi.org/10.1007/s10689-016-9890-8. (PMID: 10.1007/s10689-016-9890-826920353)
Bennet P, Phelps C, Hilgart K, Hood K, Brain K, Murray A (2011) Concerns and coping during cancer genetic risk assessment. Psychooncology 21(6):611–617. https://doi.org/10.1002/pon.1938. (PMID: 10.1002/pon.1938)
Negromonte MRO, Araujo TCCF (2011) Impact of the clinical management of pain: evaluation of stress and coping among health professionals. Rev Lat Am Enfermagem 19(2):238–244. https://doi.org/10.1590/s0104-11692011000200003. (PMID: 10.1590/s0104-1169201100020000321584368)
Sant'Ana RO, Picanço-Albuquerque CG, Silva-Fernandes IJL, Silva PGB, Bezerra MJB, Luciano MCS, Lima MVA (2020) Prevalence of pathogenic non-BRCA 1/2 gene variants in patients with suspected hereditary breast and ovarian cancer at a referral hospital in northeastern Brazil. J Clin Oncol 38:e13602–e13602. (PMID: 10.1200/JCO.2020.38.15_suppl.e13602)
فهرسة مساهمة: Keywords: Anxiety; Breast cancer; Depression; Hereditary breast and ovarian carcinoma syndrome; Quality of life
تواريخ الأحداث: Date Created: 20201106 Date Completed: 20210611 Latest Revision: 20210611
رمز التحديث: 20221213
DOI: 10.1007/s00520-020-05867-2
PMID: 33155091
قاعدة البيانات: MEDLINE
الوصف
تدمد:1433-7339
DOI:10.1007/s00520-020-05867-2